Overview

A Study of KY1005 in Healthy Volunteers

Status:
Completed

Trial end date:
2018-03-30

Target enrollment:

Participant gender:

Summary

This is a single and multiple ascending dose, placebo-controlled, double-blind, Phase 1 study to evaluate the safety and tolerability of KY1005 in healthy volunteers.

Phase:

Phase 1

Details

Lead Sponsor:

Kymab Limited